Anti-inflammatory and immunomodulatory activities of rifamycin SV

International Journal of Antimicrobial Agents

Volumn 42, Issue 2, 2013, Pages 182-186

  Rosette, Caridad ^a   Buendia Laysa, Fernando ^a   Patkar, Seema ^a   Moro, Luigi ^b   Celasco, Giuseppe ^b   Bozzella, Roberta ^b   Ajani, Mauro ^b   Gerloni, Mara ^a  

^a Cosmo Bioscience Inc ^*  (United States)

^b Cosmo Pharmaceuticals SpA ^*  (Italy)

Author keywords

CD4 T cell; Colonic cells; Cytokine secretion; Immunomodulation; Rifamycin SV; Rifaximin

Indexed keywords

INTERLEUKIN 6; INTERLEUKIN 8; RANTES; RIFAMYCIN; RIFAXIMIN; TUMOR NECROSIS FACTOR ALPHA;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CD4+ T LYMPHOCYTE; CELL STRAIN HT 29; CELL STRAIN THP 1; CELL VIABILITY; COLON MUCOSA; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; DRUG MECHANISM; EPITHELIUM CELL; HUMAN; HUMAN CELL; IMMUNOMODULATION; IN VITRO STUDY; INFLAMMATION; MACROPHAGE; MONOCYTE; PRIORITY JOURNAL;

EID: 84880282089     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2013.04.020     Document Type: Article

References (15)

1. N. Bergamini, G. Fowst, and S.V. Rifamycin A review Arzneimittelforschung 15 Suppl. 1965 951 1002
2. C. Scarpignato, and I. Pelosini Rifaximin, a poorly absorbed antibiotic: pharmacology and clinical potential Chemotherapy 51 Suppl. 1 2005 36 66 (Pubitemid 40663190)
3. I. Caruso Twenty years of experience with intra-articular rifamycin for chronic arthritides J Int Med Res 25 1997 307 317 (Pubitemid 27511098)
4. S. Spisani, S. Traniello, C. Martuccio, O. Rizzuti, and L. Cellai Rifamycins inhibit human neutrophil functions: new derivatives with potential antiinflammatory activity Inflammation 21 1997 391 400 (Pubitemid 27409958)
5. S. Fiorucci, E. Distrutti, A. Mencarelli, M. Barbanti, E. Palazzini, and A. Morelli Inhibition of intestinal bacterial translocation with rifaximin modulates lamina propria monocytic cells reactivity and protects against inflammation in a rodent model of colitis Digestion 66 2002 246 256 (Pubitemid 36578775)
6. C. Quattrocchi, K. Mangano, C. Aiello, A. Milasi, G. Celasco, and L. Moro Evaluation of the activity in DNB-induced colitis in rats and on IFNγ production in ConA-stimulated rat splenocytes J Crohn's Colitis 3 2009 S131 S132
7. H.M. Ziglam, I. Daniels, and R.G. Finch Immunomodulating activity of rifampicin J Chemother 16 2004 357 361 (Pubitemid 39049886)
8. B. Vitali, F. Perna, K. Lammers, S. Turroni, P. Gionchetti, and P. Brigidi Immunoregulatory activity of rifaximin associated with a resistant mutant of Bifidobacterium infantis Int J Antimicrob Agents 33 2009 387 389
9. H. Huang, A. Fletcher, Y. Niu, T.T. Wang, and L. Yu Characterization of lipopolysaccharide-stimulated cytokine expression in macrophages and monocytes Inflamm Res 61 2012 1329 1338
10. L. Weglarz, J. Wawszczyk, A. Orchel, M. Jaworska-Kik, and Z. Dzierzewicz Phytic acid modulates in vitro IL-8 and IL-6 release from colonic epithelial cells stimulated with LPS and IL-1β Dig Dis Sci 52 2007 93 102 (Pubitemid 46127369)
11. S.B. Menees, M. Maneerattannaporn, H.M. Kim, and W.D. Chey The efficacy and safety of rifaximin for the irritable bowel syndrome: a systematic review and meta-analysis Am J Gastroenterol 107 2012 28 35
12. K.J. Khan, T.A. Ullman, A.C. Ford, M.T. Abreu, A. Abadir, and J.K. Marshall Antibiotic therapy in inflammatory bowel disease: a systematic review and meta-analysis Am J Gastroenterol 106 2011 661 673
13. A.C. Ford, and N.J. Talley Mucosal inflammation as a potential etiological factor in irritable bowel syndrome: a systematic review J Gastroenterol 46 2011 421 431
14. D.J. Farrell, S.D. Putnam, D.J. Biedenbach, L. Moro, R. Bozzella, and G. Celasco In vitro activity and single-step mutational analysis of rifamycin SV tested against enteropathogens associated with traveler's diarrhea and Clostridium difficile Antimicrob Agents Chemother 55 2011 992 996
15. R. Cianci, F. Iacopini, L. Petruzziello, G. Cammarota, F. Pandolfi, and G. Costamagna Involvement of central immunity in uncomplicated diverticular disease Scand J Gastroenterol 44 2009 108 115